Zeus Hygia's Metaberine® Clinical Study Published, Demonstrating Metabolic Health Benefits at just 200 mg Daily
Aug 17, 2026
Hyderabad (Telangana) [India], August 17: Zeus Hygia Lifesciences, an innovator in nutraceutical solutions, today announced the publication of a clinical study evaluating Metaberine®, its bio-optimised berberine formulation developed using proprietary BioSOLVE® Technology. Published in the International Journal of Clinical Trials, the randomized, double-blind, placebo-controlled crossover trial found that Metaberine® at 200 mg per day significantly improved multiple markers of metabolic health in adults at metabolic risk.